Cargando…
ZIF-8 as a promising drug delivery system for benznidazole: development, characterization, in vitro dialysis release and cytotoxicity
Chagas disease (CD), caused by the flagellate protozoan Trypanosoma cruzi, is one of the major public health problems in developing countries. Benznidazole (BNZ) is the only drug available for CD treatment in most countries, however, it presents high toxicity and low bioavailability. To address thes...
Autores principales: | de Moura Ferraz, Leslie Raphael, Tabosa, Alinne Élida Gonçalves Alves, da Silva Nascimento, Débora Dolores Souza, Ferreira, Aline Silva, de Albuquerque Wanderley Sales, Victor, Silva, José Yago Rodrigues, Júnior, Severino Alves, Rolim, Larissa Araújo, de Souza Pereira, Jorge José, Rolim-Neto, Pedro José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545170/ https://www.ncbi.nlm.nih.gov/pubmed/33033328 http://dx.doi.org/10.1038/s41598-020-73848-w |
Ejemplares similares
-
Benznidazole in vitro dissolution release from a pH-sensitive drug delivery system using Zif-8 as a carrier
por: de Moura Ferraz, Leslie Raphael, et al.
Publicado: (2021) -
Benznidazole
por: Soares-Sobrinho, José Lamartine, et al.
Publicado: (2008) -
From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
por: Gomes, Daniele Cavalcante, et al.
Publicado: (2023) -
Hepatic changes by benznidazole in a specific treatment for Chagas disease
por: Pavan, Tycha Bianca Sabaini, et al.
Publicado: (2018) -
Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain
por: Fonseca, Kátia da Silva, et al.
Publicado: (2021)